Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shu-guang Peng"'
Publikováno v:
BioMed Research International, Vol 2018 (2018)
BioMed Research International
BioMed Research International
Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPARγ) and used to treat hyperglycemia and type 2 diabetes; however, its clinical application has been confounded by adverse side effects. Here, we ass
Autor:
Chun-sheng Xiao, Song-yi Zhao, Xiao-hua Deng, Shu-guang Peng, Yan Ding, Qing-ming Zhou, Juan Li, Ri-sheng Hu
Publikováno v:
JOURNAL OF HUNAN AGRICULTURAL UNIVERSITY. 39:570-579
Publikováno v:
JOURNAL OF HUNAN AGRICULTURAL UNIVERSITY. 37:143-146
Publikováno v:
JOURNAL OF HUNAN AGRICULTURAL UNIVERSITY. 37:26-30